Sorry, I don't understand your search. ×
Back to Search Start Over

Hyperkalemia Risk Possible With Recalled Potassium Chloride ER Capsules

Authors :
Park, Brian
Source :
MPR Monthly Prescribing Reference. June 26, 2024
Publication Year :
2024

Abstract

Glenmark Pharmaceuticals is recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750mg) 10 mEq K due to dissolution failure. Potassium Chloride Extended-Release Capsules are used in the treatment of [...]

Subjects

Subjects :
Drug therapy
Product defects and recalls
Hyperkalemia -- Drug therapy

Details

Language :
English
ISSN :
08830266
Database :
Gale General OneFile
Journal :
MPR Monthly Prescribing Reference
Publication Type :
Periodical
Accession number :
edsgcl.798935384

Tools

Authors Abstract Subjects Details